Collaborative Care in Primary Care: Substance Abuse

 

Primary care is the setting through which most individuals access the healthcare system, making it the prime setting for identifying and initiating substance[C1]  use disorder treatment. Integrating treatment professionals into the primary care setting can enhance the quality and effectiveness of substance use services, leading to better patient outcomes and lower costs.

This course will educate learners about how substance abuse problems can be addressed in the context of collaborative care. Evidence-based strategies for providing screening, brief Intervention, and referral to treatment that are appropriate in primary care will also be discussed.


 [C1]Initiating treatment?



$20.00

Hours: 1.25
REL-PI-0-P4PC46

Certificates

Certificates provided by accrediting body (10 Match)

California Board of Registered Nursing

1.25 HOURS


Provider approved by the California Board of Registered Nursing, CEP# 13791

Nurses will receive 1.25 contact hours for participating in this course.

District of Columbia Board of Nursing

1.2 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 1.20 contact hours for participating in this course.

Florida Board of Nursing CE

1.0 HOURS


Florida Board of Nursing CE Provider #: 50-290

Nurses will receive 1.00 contact hours for participating in this course.

American Nurses Credentialing Center

1.25 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 1.25 contact hours for participating in this course.

Georgia Board of Nursing

1.25 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 1.25 contact hours for participating in this course.

Accreditation Council for Continuing Medical Education

1.25 HOURS


Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Relias LLC designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

South Carolina Board of Nursing

1.25 HOURS


This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]

Florida Board of Medicine

1.25 HOURS


Florida Board of Medicine CE Provider #: 50-290

Florida Physician Assistants

1.25 HOURS


West Virginia Board of Registered Nursing

1.25 HOURS


Course Details

Course Code: REL-PI-0-P4PC46
Hours: 1.25
Type: Online Course
Content Expiration Date: 3/31/2021
Learning Objectives:
Identify levels of substance use, misuse, and disorders according to diagnostic criteria.
Discuss problems related to substance misuse and disorders.
Discuss evidence-based practices for treatment of Substance Use Disorders (SUDs) in collaborative care.

Outline:

Section 1: Introduction




  1. About This Course

  2. Learning Objectives



Section 2: Substance Use, Misuse, and Disorders




  1. Defining Substance Use, Misuse, and Disorders

  2. The Problem

  3. Review

  4. Summary



Section 3: Identification and Treatment of SUDs in Collaborative Care




  1. Integrating Care of Patients with SUDs into Primary Care

  2. Roles and responsibilities in Collaborative Care for the Treatment of SUDs

  3. Screening, Brief Intervention, and Referral to Treatment

  4. Medication-Assisted Treatment

  5. Review

  6. Summary



Section 4: SUD-Specific Recommendations in Primary Care




  1. Alcohol Use Disorder

  2. Opioid Use Disorder

  3. Review

  4. Summary



Section 5: Conclusion




  1. Summary

  2. Course Contributors

  3. Resources

  4. References

  5. Congratulations!

  6. Exam

  7. BrainSparks


Expert Reviewer: Christopher Reist, MD, MBA
Dr. Reist is an Associate Professor (with tenure) in the Department of Psychiatry and Human Behavior at the University of California, Irvine. He also serves as Assistant Dean in the College of Medicine and the Director of Medical Research for the Long Beach Veterans Affairs Healthcare System. Formerly, he served as Chief of Mental Health, overseeing full service mental health care delivery to over 40,000 enrollees at the Long Beach VA Healthcare System. For the past 12 years, he has served as Associate Director of the Southern California VA Mental Illness Research, Education, and Clinical Center (MIRECC), which is focused on improving long-term outcomes in chronic psychotic disorders through basic/clinical research and dissemination of evidence-based practices. Dr. Reist’s clinical interests include schizophrenia, impulsivity, PTSD, pharmacogenomics, and psychopharmacology. NARSAD, NIMH, and VA Medical Research have supported his research. He has served as principal investigator on over 25 clinical trials in areas including schizophrenia, depression, bipolar disorder and impulsivity. He is a member of professional societies, including the American Psychiatric Association, Pacific Rim Association for Clinical Pharmacogenetics, and the Society of Biological Psychiatry. He is a Distinguished Fellow of the Psychiatric Association, has been recognized as an Exemplary Psychiatrist by the National Alliance for the Mentally Ill, and is included in Best Doctors 2007-2010. He is the author of two books, Psychiatry and Psychiatric Drugs, which have been widely used by trainees for the past 15 years. He has over 50 scientific articles that have been published in high-impact journals, including Molecular Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry, American Journal of Psychiatry, and Nature Biotechnology. Lastly, he has extensive experience in psychiatric education that include organizing CME conferences and developing web content that provide information on psychiatric disorders and treatment. Disclosure: Christopher Reist, MD, MBA discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Alkermes as Grant/Research Support
Staff Writer: Rebecca Smallwood, MBA, RN
Rebecca Smallwood, MBA, RN, has over 25 years of experience across a spectrum of healthcare settings including: rural and urban acute care hospitals, public health, ambulatory surgery center, higher education, and commercial organizations. Her roles have included: medical/surgical, ED, and OR staff nurse and charge nurse positions; director of health services / school nurse for PK-12th grades; public health epidemiology and bioterrorism preparedness professional; Infection control practitioner; quality management specialist; organizational development specialist; and educator. Prior to joining Relias Learning as a SME and Content Writer, she provided clinical and healthcare learning and development consultation to Swank Healthcare and was the Director of Education Services for Health.edu, a division of Texas Tech University Health Sciences Center. She has authored over 100 live and web-based educational presentations and articles on clinical, patient safety, regulatory, leadership, patient experience, and performance improvement topics. Rebecca earned a diploma in nursing from Methodist Hospital School of Nursing in Lubbock, Texas in 1989 and an MBA in Healthcare Administration from Wayland Baptist University in 2010.  Disclosure: Rebecca Smallwood, MBA, RN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: Nurses; Physician Assistants; Physicians; in the following settings: All Healthcare Settings.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support by calling (800) 381-2321 or emailing [email protected]